Catalyst Wire Dossier Catalyst Wire Dossier

ALVAC-HIV Vaccine (V520-019)

ALVAC-based HIV vaccine
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ALVAC-HIV Vaccine (V520-019), covering 2015-05-28 to 2015-05-28. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Safety, Tolerability and Immunogenicity of a 1-Dose Regimen of MRKAd5 HIV-1 Gag Vaccine Versus the ALVAC_HIV Vaccine (V520-019) [Phase 1]

See pricing